88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


International Self-Care Day: Dimora Medical Highlights Wound Care as an Essential Part of Everyday Self-Care NEW YORK , July 25, 2026 /PRNewswire/ -- As International Self-Care Day draws attention to the importance of maintaining health around the clock, the concept of 24/7 self-care continues to gain momentum ... 2026-07-25T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical WALTHAM, Mass. , July 24, 2026 /PRNewswire/ -- Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients PALMA DE MALLORCA, Spain , July 24, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406 SHANGHAI , July 24, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 24, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fapon Showcases AI-Engineered Enzymes and Alzheimer's Solutions at ADLM 2026, Reinforcing North American Commitment ANAHEIM, Calif. , July 24, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider with deepening roots in North America, will exhibit at ADLM 2026 from July 26 to 30 in Anaheim, California. The company ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN) TAIPEI , July 23, 2026 /PRNewswire/ -- AnHorn Medicines today announced the successful completion of the first subject first dose in the Phase I clinical trial of AH-008, a first-in-class neuroprotective ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering SHANGHAI , July 23, 2026 /PRNewswire/ -- Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain ... 2026-07-23T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH BEIJING , July 23, 2026 /PRNewswire/ -- Haisco Pharmaceutical Group claimed today their independently developed Class 1 innovative drug, Ciprocopan Succinate Tablets (development code: HSK39297), ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases Partnership grants Ignaz Semmelweis Institute access to Nona's H2L2 Harbour Mice ® transgenic mouse technology platform for translational antibody research ... 2026-07-23T Biotechnology Higher Education Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals